Different anesthesia management in preterm infants undergoing surgeries for retinopathy of prematurity: A retrospective study / 北京大学学报(医学版)

OBJECTIVE@#To evaluate the effect of different anesthesia management on clinical outcomes in former prematurely born infants undergoing surgeries for retinopathy of prematurity (ROP).@*METHODS@#In this retrospective study, electronic medical record database was searched for all former prematurely born infants (gestational age < 37 weeks and post conceptual age < 60 weeks) who received ROP surgery under inhalational general anesthesia between November 2016 and October 2018. The patients were divided into two groups based on anesthesia management: laryngeal mask airway (LMA) insertion without intravenous muscle relaxant injection and with pressure support ventilation (LMA group) or airway secured with endotracheal tube (ETT) with intravenous muscle relaxant injection and pressure controlled ventilation (ETT group). Primary outcomes included perioperative adverse events and complications. Extubation time and length of stay after surgery were also recorded.@*RESULTS@#Sixty eight preterm infants in the LMA group and 100 preterm infants in the ETT group were included. The incidence of adverse events during surgery (including airway management change and desaturation) was similar in LMA group and ETT group (4.4% vs. 1.0%, P =0.364). During the early recovery period after surgery, the incidence of difficult extubation (extubation time >30 min) was significantly lower in LMA group compared with ETT group (4.4% vs.15.0%, RR=0.262, 95%CI:0.073－0.942, P=0.029). The incidence of respiratory events was similar between the two groups (20.6% vs. 27.0%, P =0.342). However, the incidence of apnea was significantly lower in the LMA group than in the ETT group (5.9% vs.19.0%, RR=0.266, 95%CI: 0.086－0.822, P =0.015). No significant difference was observed between the LMA group and ETT group in incidences of cardiovascular events (0% vs. 1.0%, P =1.000) and unplanned admission to neonatal intensive care unit (5.9% vs. 7.0%, P=0.774). No airway spasm, re-intubation, aspiration or regurgitation was observed during early recovery. During late recovery after returning to ward, the incidence of adverse events was also similar between the two groups (0% vs. 2.0%, P =0.241). The median (IQR) extubation time was 6 (5, 10) min in LMA group and 10 (6, 19) min in ETT group (P < 0.001). The median length of stay after surgery was significantly shortened in LMA group compared with ETT group [20 (17, 22) hours vs. 22 (17, 68) hours, P =0.002].@*CONCLUSION@#Compared with endotracheal intubation with intravenous muscle relaxant injection, laryngeal mask airway insertion without muscle relaxant could achieve an early extubation, and reduce the incidence of apnea during early recovery period in former prematurely born infants undergoing ROP surgery.

Peribulbar block combined with general anesthesia in babies undergoing laser treatment for retinopathy of prematurity: a retrospective analysis / Bloqueio peribulbar combinado com anestesia geral em bebês submetidos a tratamento a laser para retinopatia da prematuridade: uma análise retrospectiva

Abstract Background and objectives Currently there is no agreement regarding which one is the most adequate anesthetic technique for the treatment of retinopathy of prematurity. Peribulbar block may reduce the incidence of oculocardiac reflex and postoperative apnea. The goal of this study was to report the outcomes of peribulbar block, when combined with general anesthesia, for the laser treatment for retinopathy of prematurity, in premature babies. Methods A retrospective analysis of anesthetic records of all babies who underwent laser treatment for retinopathy of prematurity from January 2008 through December 2015 in a tertiary hospital was performed. Results During that period a total of six babies was submitted to laser treatment for retinopathy of prematurity, all under peribulbar block combined with general anesthesia. A single infratemporal injection of 0.15 mL.kg−1 per eye ropivacaine 1% or 0.75% was performed. At the end of the procedure, all babies resumed spontaneous ventilation. No perioperative complications were reported. Conclusions Peribulbar block was a safe anesthetic technique in our sample considered.

Resumo Justificativa e objetivos Até o momento não há um consenso sobre a técnica anestésica mais adequada para o tratamento de retinopatia da prematuridade. O bloqueio peribulbar pode reduzir a incidência de reflexo oculocardíaco e apneia no pós-operatório. O objetivo deste estudo foi relatar os resultados do bloqueio peribulbar, quando combinado com anestesia geral, para o tratamento a laser de retinopatia da prematuridade em bebês prematuros. Métodos Uma análise retrospectiva dos registros anestésicos de todos os bebês submetidos ao tratamento a laser para retinopatia da prematuridade de janeiro de 2008 a dezembro de 2015 foi realizada em um hospital terciário. Resultados Durante esse período, seis bebês foram submetidos ao tratamento a laser para retinopatia da prematuridade, todos sob bloqueio peribulbar combinado com anestesia geral. Uma injeção infratemporal única de ropivacaína a 1% ou 0,75% (0,15 mL.kg−1) foi administrada por olho. No fim do procedimento, todos os bebês retomaram a ventilação espontânea. Não foram relatadas complicações perioperatórias. Conclusões O bloqueio peribulbar foi uma técnica anestésica segura em nossa amostra considerada.

Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose? / Qual a dose de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva: menor ou maior dose?

ABSTRACT Purpose: To compare 0.5 mg and 0.625 mg of bevacizumab for treating aggressive posterior retinopathy of prematurity (AP-ROP). Methods: The medical records of patients with AP-ROP who were administered intravitreal bevacizumab (IVB) as a primary treatment at a university clinic were evaluated retrospectively. Five eyes of three patients (Group 1) who received 0.625 mg/0.025 ml IVB and 10 eyes of another five patients (Group 2) who received 0.5 mg/0.02 ml IVB were evaluated. Laser photocoagulation was used as additional treatment after relapses. Anatomic results and complications were evaluated in both groups. Results: We evaluated 15 eyes of eight patients (four girls and four boys) with a flat demarcation line at posterior zone 2 and plus disease or stage-3 disease in this study. The mean gestational age of the three babies in Group 1 was 26 ± 1 weeks and the mean birth weight was 835.33 ± 48.01 g. The corresponding values were 25.2 ± 1.6 weeks and 724 ± 139.03 g, respectively, for the five babies in Group 2. Retinal vascularization was completed at a mean postmenstrual duration of 53.6 ± 1.5 weeks without additional treatment in the five eyes in Group 1. Laser photocoagulation for relapse was administered to five of the 10 eyes in Group 2. Retinal vascularization was completed at a mean postmenstrual duration of 47.6 ± 1.5 weeks in the remaining five eyes. None of the patients developed complications such as cataract, glaucoma, retinal tear, retinal or vitreous hemorrhage, or retinal detachment. Conclusion: Although lower IVB doses in the treatment of AP-ROP are expected to be safer in terms of local and systemic side effects in premature infants, these patients may require additional treatment with IVB or laser photocoagulation.

RESUMO Objetivo: Comparar doses de 0,5 mg e 0,625 mg de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva (ROP-PA). Métodos: os registros médicos de pacientes com ROP-PA que receberam bevacizumab intravítreo (IVB) como tratamento primário em uma clínica universitária foram avaliados retrospectivamente. Houve 5 olhos de 3 casos (Grupo 1) que receberam 0,625 mg/0,025 ml de IVB e 10 olhos de outros 5 casos (Grupo 2) que receberam 0,5 mg/0,02 ml de IVB. A fotocoagulação com laser foi utilizada como tratamento adicional para casos de recidiva. Os resultados e complicações anatômicas foram avaliados em ambos os grupos. Resultados: Incluímos os 15 olhos de 8 pacientes (4 meninas e 4 meninos) com linha de demarcação plana na zona posterior 2 e doença "plus" (dilatação e tortuosidade vascular) neste estudo. A idade gestacional média dos três bebês no Grupo 1 foi de 26 ± 1 semana e o peso médio ao nascer foi de 835,33 ± 48,01 g, enquanto esses valores foram de 25,2 ± 1,6 semanas e 724 ± 139,03 g, respectivamente, para os cinco bebês do Grupo 2. A vascularização da retina foi completada com uma duração média pós-menstrual de 53,6 ± 1,5 semanas sem tratamento adicional nos cinco olhos no Grupo 1. A fotocoagulação a laser foi administrada devido à recaída em 5 dos 10 olhos do Grupo 2. A vascularização da retina foi completada em média de 47,6 ± 1,5 semanas do período pós-menstrual nos cinco olhos restantes. Nenhum dos casos desenvolveu complicações, como catarata, glaucoma, rasgo da retina, hemorragia retiniana ou vítrea ou descolamento da retina. Conclusão: Embora as doses mais baixas de IVB no tratamento de ROP-PA sejam mais seguras em termos de efeitos colaterais locais e sistêmicos em prematuros, esses pacientes podem precisar de tratamento adicional com IVB ou fotocoagulação a laser.

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity / Comparação de ranibizumab e bevacizumab intravítreos no tratamento da retinopatia da prematuridade

ABSTRACT Purpose: To compare the efficacy of intravitreal ranibizumab and bevacizumab treatment for type 1 retinopathy of prematurity (ROP). Methods: 36 eyes of 20 patients with type 1 ROP who received anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections between August 2011 and February 2013 were retrospectively evaluated. Fifteen eyes of 8 patients received 0.25 mg ranibizumab (group 1), and 21 eyes of 12 patients received 0.625 mg bevacizumab (group 2). Eyes were examined by indirect ophthalmoscopy on the first day, third day, first week, and first month and as required after injections. Laser photocoagulation was performed in cases with progression of ROP. Results: The mean gestation time was 26.2 ± 2.7 weeks in group 1 patients and 27.1 ± 2.5 weeks in group 2 patients. No statistical difference in the time of gestation was observed between the two groups. The mean follow-up period was 20 ± 4.5 months. Laser photocoagulation was performed in 6 of 15 eyes from group 1 and 2 of 21 eyes from group 2. No eyes developed retinal detachment during the follow-up period. Conclusion: Ranibizumab and bevacizumab showed an efficacy in the treatment of type 1 ROP. The incidence of disease relapse was higher in eyes which received ranibizumab. Further randomized, controlled clinical trials are required to compare the efficacy of ranibizumab and bevacizumab.

RESUMO Objetivo: Comparar a eficácia de ranibizumab e bevacizumab intravítreos no tratamento da retinopatia da prematuridade (ROP) tipo 1. Método: Foram avaliados retrospectivamente 36 olhos de 20 pacientes com retinopatia da prematuridade tipo 1 que receberam injeções intravítreas anti fator de crescimento endotelial vascular (anti VEGF) entre agosto de 2011 e fevereiro 2013. Quinze olhos de 8 pacientes receberam 0,25 mg ranibizumab (grupo 1) e 21 olhos de 12 pacientes receberam 0,625 mg bevacizumab (grupo 2). Os olhos foram examinados por oftalmoscopia indireta no primeiro dia, terceiro dia, primeira semana, e primeiro mês e conforme necessário após a injeção. Fotocoagulação com laser foi realizada quando foi detectada progressão da retinopatia da prematuridade. Resultados: Média do tempo de gestação para os pacientes do grupo 1 foi de 26,2 ± 2,7 semanas, enquanto para o grupo 2 foi de 27,1 ± 2,5 semanas. Não houve diferença estatística em relação ao tempo de gestação entre os grupos. A média de acompanhamento foi de 20 ± 4,5 meses. Fotocoagulação a laser foi realizada a 6 dos 15 olhos do grupo 1 e 2 dos 21 olhos do grupo 2. Nenhum dos olhos desenvolveu descolamento de retina no período de acompanhamento. Conclusão: O ranibizumab e bevacizumab são eficazes no tratamento da retinopatia da prematuridade tipo 1. Incidência de progressão foi maior nos olhos que receberam ranibizumab. Ensaios clínicos controlados futuros são necessários para comparar esses dois medicamentos.

Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity / Avaliação dos resultados após 2 anos de injeção de bevacizumab intravítreo para retinopatia da prematuridade posterior agressiva

ABSTRACTPurpose:To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).Methods:Medical records of 40 infants were retrospectively reviewed. Group I included infants who had received IVB injections for APROP. Group II included infants who underwent laser treatment for APROP. Anatomic and refractive outcomes and the presence of anisometropia and strabismus were assessed at follow-up examinations.Results:Group I included 48 eyes of 25 infants (11 males) with a mean gestational age (GA) of 26.40 ± 1.82 weeks and a mean birth weight (BW) of 901.40 ± 304.60 g. Group II included 30 eyes of 15 infants (6 males) with a mean GA of 27.30 ± 1.82 weeks and a mean BW of 941.00 ± 282.48 g. GA, BW, and gender distributions were similar between groups (P=0.187, P=0.685, and P=1.000, respectively). Refractive errors were significantly less myopic in group I (0.42 ± 3.42 D) than in group II (-6.66 ± 4.96 D) at 2 years (P=0.001). Significantly higher rates of anisometropia and strabismus were observed in group II than in group I (P=0.009 and P=0.036, respectively).Conclusions:The study demonstrated that IVB monotherapy can be useful in the treatment of APROP. The decreased incidence of early unfavorable refractive and functional outcomes in the IVB group compared with the laser group showed a potential benefit for patients treated with IVB, and this needs to be better evaluated in future prospective studies.

RESUMOObjetivo:Avaliar a evolução de 2 anos em crianças que receberam bevacizumab intravítreo (IVB) como monoterapia para retinopatia da prematuridade posterior agressiva (APROP).Métodos:Arquivos médicos de 40 crianças foram revisados retrospectivamente. Grupo I incluiu as crianças que tiveram injeções IVB para APROP. Grupo II foi composto por crianças que se submeteram a tratamento a laser para APROP. Os resultados anatômicos e refracionais, presença de anisometropia e estrabismo foram avaliados durante exames de acompanhamento.Resultados:Grupo I incluiu 48 olhos de 25 crianças (11 do sexo masculino) com média de idade gestacional (GA) de 26,40 ± 1,82 semanas, e média de peso ao nascimento (BW) de 901,40 ± 304,60 g. Grupo II incluiu 30 olhos de 15 crianças (6 do sexo masculino) com GA de 27,30 ± 1,82 semanas e BW de 941,00 ± 282,48 g. GA, BW e distribuição por sexo foram semelhantes entre os grupos (p=0,187, p=0,685, p=1,000, respectivamente). Nenhuma anormalidade anatômica foi observada em ambos os grupos. Erro refrativo foi significativamente menos míope no grupo I (0,42 ± 3,42 D) do que o grupo II (-6,66 ± 4,96 D) em exames aos 2 anos (p=0,001). Houve significativamente maior taxa de anisometropia e estrabismo no grupo II em relação ao grupo I (p=0,009, p=0,036, respectivamente).Conclusões:O estudo demonstrou que a monoterapia IVB pode ser útil no tratamento de APROP. A diminuição da incidência de resultados refracionais e funcionais desfavoráveis precoces no grupo IVB em comparação com o grupo do laser mostraram um benefício potencial para os pacientes tratados com IVB, e isto tem de ser melhor avaliado em estudos prospectivos no futuro.

Prematurez extrema y oxigeno prolongado sin control como factores determinantes en la retinopatía del prematuro y cirugía láser

La retinopatía del prematuro es una enfermedad que afecta los vasos sanguíneos de la retina, es frecuente en niños prematuros, con una incidencia que va de 12% a 78%. La complicación más grave es el desprendimiento de retina con ceguera permanente. En nuestro país es la principal causa de ceguera. Objetivo: Establecer si la Prematurez extrema y el oxígeno prolongado sin control actúan como factores determinantes en la retinopatía y cirugía láser en los recién nacidos internados en la unidad de terapia intensiva del Hospital Pablo Soria de la Provincia de Jujuy en el año 2011. Método: Se realizó una investigación observacional, descriptiva, en la Unidad de Cuidados Intensivos del Servicio de Neonatología del Hospital Pablo Soria, en los meses de enero a diciembre del 2011; con la revisión de 73 historias clínicas de recién nacidos con diagnóstico de retinopatía, se buscó evaluar si la Prematurez extrema y la exposición a la oxigenoterapia prolongada sin control son factores determinantes en la retinopatía, y cirugía láser, Se analizaron las variables peso, edad gestacional, tiempo de oxigenoterapia, grado de retinopatía, cirugías y control de oxígeno. Resultado: Se observó que el peso es un factor importante en la fisiopatología de la retinopatía sobre todo en lo que respecta formación de los distintos grados de Rop y las cirugías, no así la edad gestacional, porque la presencia de esta patología en recién nacidos mayores de 34 semanas de edad gestacional es frecuente, esto se debe considerar al realizar los screening oftalmológicos, la exposición prolongada al oxigeno sin control por tiempo mayor a quince días también es un factor agravante en esta patología, pero no solamente en los prematuros de muy bajo peso, sino también en los mayores de 1400 grs...

Retinopathy of prematurity is a disease that affects the blood vessels of the retina, is common in premature infants, with an incidence ranging from 12% to 78%. The most serious complication is retinal detachment with permanent blindness. In Spain is the leading cause of blindness. Objective: To establish whether the extreme prematurity and prolonged uncontrolled oxygen act as determinants of retinopathy and laser surgery in newborns hospitalized in the intensive care unit of Hospital Pablo Soria province of Jujuy in 2011. Method: An observational investigation was conducted, descriptive, in the Intensive Care Unit of Neonatology Service of Hospital Pablo Soria, in the months from January to December 2011; with review of 73 medical records of newborns diagnosed with retinopathy, is looking to assess whether extreme prematurity and exposure to prolonged oxygen therapy without control are determining factors in retinopathy, and laser surgery, variable weight were analyzed gestational age , duration of oxygen therapy, degree of retinopathy, surgeries and oxygen control. Results: It was observed that the weight is an important factor for retinopathy pathophysiology especially regarding formation of different degrees of Rop and surgeries, not gestational age, because the presence of this disease in infants older 34 weeks gestational age is common, this should be considered when making eye screening, the prolonged oxygen exposure unchecked wholesale fifteen days is also an aggravating factor in this disease, but not only in premature very low weight, but also in those over 1400 g...

Long-term Results of Lens-sparing Vitrectomy for Progressive Posterior-type Stage 4A Retinopathy of Prematurity

PURPOSE: To assess the long-term anatomic and visual outcomes and associated complications of lens-sparing vitrectomy (LSV) in infants with progressive posterior-type tractional retinal detachment (TRD) associated with stage 4A retinopathy of prematurity (ROP). METHODS: In a retrospective case series, the medical records of consecutive patients who presented with progressive posterior-type stage 4A ROP and underwent LSV between 1999 and 2007 were reviewed. Retinal attachment status, visual acuity, and development of postoperative complications were assessed. RESULTS: Eleven eyes of 9 patients were included. The mean follow-up period was 4.6 years. In 8 eyes (73%), plus disease was present at the time of LSV. In 3 eyes (27%), 2 (66%) without plus disease and 1 (13%) with plus disease, the retina remained reattached in the end, while 8 eyes (73%) had TRD on final examination. Two eyes with reattached retinas showed favorable visual acuity. In those eyes with detached retinas, 5 (68%) showed no light perception. When surgery for ROP was unsuccessful, development of cataract, corneal opacity, or glaucoma was common. CONCLUSIONS: The long-term anatomic success rate of LSV for progressive posterior-type stage 4A ROP was low, especially in the presence of plus disease at the time of LSV. Anatomical reattachment is very important for preventing complications and gaining better visual outcomes.

Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes.

Aim: The aim was to study the structural sequelae and refractive outcome after laser treatment for Type 1 prethreshold retinopathy of prematurity (ROP) in Asian Indian eyes. Materials and Methods: A retrospective chart review of infants with Type 1 prethreshold ROP (defined according to the Early Treatment for Retinopathy of Prematurity study) undergoing laser treatment at a tertiary center between January 2004 and December 2008 was done. The 1-year outcome of infants was analyzed. Results: Sixty-nine eyes of 36 infants were included. The mean birth weight was 1121.69 ± 254.81 g and the gestational age was 28.99 ± 2.03 weeks. Sixty-five eyes (94.2%) had zone 2 and 4 (5.8%) had zone 1 disease. Forty-four (63.77%) eyes had stage 2 ROP with plus disease and 25 (36.23%) eyes had prethreshold (fewer than five contiguous or eight cumulative clock hours) stage 3 ROP with plus disease. None of the eyes developed retinal structural sequelae. On cycloplegic retinoscopy, 59.4% eyes had nonsignificant hyperopia [spherical equivalent (SE) ≤ 4 D], 14.5% eyes had no refractive error (SE 0 D), 24.7% eyes had low myopia (SE < 5 D), and 1.4% eyes had high myopia (SE > 5.0 D). Eyes developing myopia were associated with a greater number of clock hours of ROP, greater number of laser spots used, and a longer time to disease regression. Two infants (5.6%) had esotropia and one (2.8%) had exotropia. Conclusion: Asian Indian infants treated for Type 1 prethreshold ROP did not develop retinal structural sequelae. Myopia was seen in nearly one-fourth of the eyes.The risk factors for myopia were a greater number of clock hours of ROP, greater number of laser spots, and a longer time to regression of ROP.

Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia.

Retinopathy of prematurity (ROP) is a significant cause of childhood blindness. The criteria for laser therapy have been revised from threshold ROP to include the earlier stage of high-risk prethreshold ROP. Laser photocoagulation is an established technique for the treatment of ROP. However, the detailed procedure and techniques for laser photocoagulation have not yet been published. Adequate and appropriate laser photocoagulation for ROP is different from the application of lasers in adult retinal vascular diseases, and many ophthalmologists need to be trained in this technique if the outreach of ROP treatment programs is to improve. Laser under topical anesthesia has been practiced in India as a preferred modality especially due to logistics and risks of general anesthesia in these pre-term babies. We discuss the details of the technique as practiced at tertiary care ophthalmic hospitals in India, so that the nuances in treatment parameters and clinical decision-making can be usefully applied to ophthalmic practice. This will ultimately lead to safe and effective treatment delivery in ROP.

Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity.

Background: While lens-sacrificing vitrectomy is the standard approach to manage Stage 5 retinopathy of prematurity (ROP), scleral buckling has been used to manage some cases of Stage 4. Lens-sparing vitrectomy was popularized by Maguire and Trese in selected cases of Stage 4 disease. Purpose: To assess the functional and visual outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 ROP. Materials and Methods: In a retrospective, interventional, consecutive case series, the records of 39 eyes of 31 patients presenting with Stage 4 retinal detachment secondary to ROP who underwent primary two or three-port lens-sparing vitrectomy from January 2000 to October 2006 were evaluated. The outcomes studied at the final follow-up visit were the retinal status, lens and medial clarity and visual acuity. Favorable anatomical outcome was defined as the retinal reattachment of the posterior pole at two months after the surgery; and favorable functional outcome was defined as a central, steady and maintained fixation, with the child following light. Results: At mean follow-up of 15 months, 74% of the eyes had a favorable anatomical outcome with single procedure. The visual status was favorable in 63%. The lens remained clear in all the eyes at the last follow-up, and the media clarity was maintained in 87%. Intraoperative complications included vitreous hemorrhage, pre-retinal hemorrhage and retinal break formation. Conclusions: Lens-sparing vitrectomy helps to achieve a favorable anatomical and functional outcome in selected cases of Stage 4 ROP.

Efficacy of scleral buckling for stage 4A retinopathy of prematurity

To evaluate the anatomical and functional outcome of scleral buckling [SB] for stage 4A retinopathy of prematurity [ROP]. Retrospective, non-comparative, consecutive, interventional case series study. Five eyes of five patients with stage 4A ROP were enrolled. All eyes were selected from consecutive patients treated with SB and then division of the encircling band. Patient characteristics, including gestational age. birth weight, gender, corrected gestational age at time of surgery, surgical procedure, anatomic outcome, ability to fix and follow and refractive changes were recorded. All eyes had a complete retinal reattachment [ +/- macular ectopia] at a mean follow-up of 43.4 months [range 38-50 months]. Final visual acuity ranged from 20/50 to 20/200. Fixation was central in 2 eyes and remaining eyes with poorer vision had eccentric fixation due to macular ectopia. Mean refractive error in spherical equivalents was -8.4 D [range -5.50 to -12.00 D]. Scleral buckling for stage 4A retinopathy of prematurity is an effective means of preventing further progression of retinal detachment. This encircling procedure induces large myopic shift by way of increasing the axial length. This highlights the importance of repeated refraction testing in these eyes to prevent refractive amblyopia

Efficacy and safety of green laser photocoagulation for threshold retinopathy of prematurity

PURPOSE: To report the efficacy and safety of green laser photocoagulation for threshold retinopathy of prematurity (ROP). METHODS: We reviewed the clinical records of the neonates who had undergone green laser photocoagulation for threshold ROP at the Federal University of Pernambuco in Brazil between January 2004 and January 2006. All procedures were conducted with local anesthetic drops. The neonates were monitored throughout the procedure by a neonatologist. A frequency-doubled solid state laser, diode-pumped, with 532 nm wavelength was used. The presence of tunica vasculosa lentis or cataract were excluded before laser treatment. The following preoperative data were obtained for each patient: age, birth weight and the grade of ROP. Postoperative data included complications associated with the laser treatment, grade of ROP and evaluation whether further surgery was necessary due to failure of laser photocoagulation. RESULTS: Twenty-two neonates underwent photocoagulation with green laser for threshold ROP. A total of 31 eyes were included in the study. The mean gestational age was 30 ± 3 weeks and the mean birth weight was 1120 ± 490 g. Regression of the disease after laser therapy was observed in 30 eyes (96.7 percent). Despite treatment one eye presented stage 4A. Only 7 eyes required repetitive laser therapy. No adverse effects such as burning anterior segment tissues or bleeding in the anterior chamber occurred. No posterior segment side-effects were observed. Cataract formation was not observed at the last follow-up examination. CONCLUSIONS: Green laser photocoagulation remains an effective and safe alternative to red laser photocoagulation and to cryotherapy in the treatment of threshold ROP.

OBJETIVOS: Avaliar a eficácia e segurança da fotocoagulação com laser verde na retinopatia da prematuridade (ROP) limiar. MÉTODOS: Foram revisados prontuários dos neonatos submetidos à fotocoagulação com laser verde para ROP limiar, na Universidade Federal de Pernambuco, entre janeiro 2004 e janeiro 2006. Tratamento foi realizado com anestesia tópica, sob monitorização de neonatologistas. Foi utilizado laser verde de estado sólido com diodo de freqüência dobrada de 532 nm. Presença de túnica vasculosa lentis ou catarata foi excluída antes do tratamento. Foram obtidos os seguintes dados pré-operatórios: idade, peso ao nascer e estágio da ROP. Dados pós-operatórios incluíram complicações associadas com o tratamento, estágio da ROP e avaliação da necessidade de cirurgia por falha do tratamento com fotocoagulação. RESULTADOS: Vinte e dois neonatos foram submetidos à fotocoagulação com laser verde para ROP limiar. Um total de 31 olhos foi incluído no estudo. A idade gestacional média foi de 30 ± 3 semanas e a média do peso ao nascer foi de 1120 ± 490 g. Regressão da doença após terapia com laser foi observada em 30 olhos (96,7 por cento). Apesar do tratamento um olho evoluiu para estágio 4A. Apenas 7 olhos precisaram de mais uma sessão de laser. Não houve efeitos adversos na câmara anterior como queimaduras ou sangramentos. Também não foram observados efeitos colaterais no segmento posterior. Formação de catarata não foi observada até o final do acompanhamento. CONCLUSÕES: A fotocoagulação com laser verde é uma alternativa efetiva e segura à fotocoagulação com laser vermelho e à crioterapia para o tratamento da ROP limiar.

Outcomes of scleral buckling for stage 4 retinopathy of prematurity in Thai children.

OBJECTIVE: To evaluate the anatomical and visual results of a primary scleral buckling procedure for the treatment of stage 4A and 4B retinopathy of prematurity (ROP) in Thai patients. MATERIAL AND METHOD: The data of premature infants treated with a primary scleral buckling procedure for stage 4 ROP from December 2000 to May 2004 were retrospectively reviewed The outcomes measures were anatomical success, visual outcomes, and refractive error at the end of follow-up. RESULTS: Sixteen eyes of ten patients underwent a scleral buckling procedure and had the mean follow-up period of 17.3 months (range 3-44 months). The anatomical success was 100% (8 of 8 eyes) in stag 4A and 50% (4 of 8 eyes) in stage 4B. At the end of the follow-up, the buckle was removed in 92% (11 of 12 eyes) of retina-attached eyes and showed a mean myopic refraction of-8.68 diopters (range -4. 75 to 13.50). Favorable visual outcome was 50% (4 of 8 eyes) in stage 4A and 12.5% (1 of 8 eyes) in stage 4B. CONCLUSION: Scleral buckling appears to play a role in reducing the progression from stage 4 to stage 5 ROP The anatomical success rate was excellent but the visual results remain challenging for these cases.

Retinopatia da prematuridade: estudo epidemiológico de 348 pacientes / Retinophaty of prematurity: epidemiologic study of 348 patients

Analisa a incidência da retinopatia da prematuridade (RP) em Teresina, os fatores de risco (peso ao nascimento e idade gestacional) e as formas de tratamento realizadas. Foram analisados os prontuários de 348 crianças prematuras na Clínica Oftalmológica do Hospital Getúlio Vargas e Instituto de Olhos do Piauí, em Teresina, PI, no período de julho/89 a março/99. As crianças no estágio 3 threshold foram submetidas à crioterapia ou laserterapia retinianas e nos estágios 4 e 5 foram submetidas à introflexão escleral, vitrectomia ou outras cirurgias. Das 348 crianças examinadas, 152 apresentaram RP no exame inicial. O peso variou de 650 a 2.400g e a idade gestacional, de 22 a 37 semanas. Quarenta e quatro crianças foram submetidas a tratamento, totalizando 75 procedimentos. Concui que a retinopatia da prematuridade apresentou alta incidência e os fatores peso e idade gestacional foram relevantes no desenvolvimento da doença, prevenindo a perda visual definitiva

Retinopatia da prematuridade grau V: tratamento cirúrgico / Stage V retinopathy of prematurity: surgical treatment

Estudamos os resultados anatômico e funcional de 10 crianças (13 olhos) com retinopatia da prematuridade grau V (ROP V) submetidas a tratamento cirúrgico. Dez olhos foram submetidos à vitrectomia fechada e 3 à vitrectomia a céu aberto no primeiro ano de vida. Onze olhos evoluiram com a retina colada ou parcialmente colada e em 2 olhos a retina permaneceu colada apesar da cirurgia. A acuidade visual piorou em 1 olho, se manteve em 7 olhos e melhorou 6 olhos. Apesar do prognóstico funcional relativamente reservado, a visäo pode melhorar em alguns casos que apresentem a retina colada e a cirurgia deve ser considerada uma importante opçäo de tratamento para estas crianças